Led by Digital Health Investor, SeedLink, Biospectal’s seed round will enable the startup to scale OptiBP, a clinical-grade blood pressure measurement and monitoring product and operations worldwide. Renowned interventional cardiologist and inventor, Fred St. Goar and SeedLink’s Tim Juergens joined Biospectal’s Board of Directors.
